Deccan Health Care Reports Q2 FY27 Consolidated PAT of ₹39.84 Lakh
Key highlights
- Deccan Health Care reported Q2 FY27 consolidated profit after tax of ₹39.84 lakh.
- Standalone Q2 FY27 profit after tax was ₹36.99 lakh for the quarter ended September 30, 2026.
- Consolidated profit after tax for H1 FY27 was ₹68.95 lakh, compared with standalone profit of ₹61.62 lakh.
- Q1 FY27 consolidated revenue was previously reported at ₹22.09 crore and net income at ₹29.1 lakh.
powered by IRIS

Deccan Health Care Limited reported consolidated profit after tax of ₹39.84 lakh for the quarter ended September 30, 2026, while standalone profit after tax was ₹36.99 lakh. For the first half of FY27, consolidated profit after tax stood at ₹68.95 lakh and standalone profit was ₹61.62 lakh.
Know Deccan Health Care inside out
Results, valuation, peers and who's buying, in one view.
What did Deccan Health Care report for Q2 FY27?
Deccan Health Care released its un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The disclosure provides separate profit figures for the company’s standalone operations and its consolidated financial statements.
On a standalone basis, Deccan Health Care recorded profit after tax of ₹36.99 lakh in Q2 FY27. Standalone profit after tax for the six months ended September 30 was ₹61.62 lakh. On a consolidated basis, the company reported profit after tax of ₹39.84 lakh for the September quarter and ₹68.95 lakh for the first half of the financial year.
The reported figures establish the company’s profit position at the end of the first six months of FY27. The available disclosure does not provide Q2 FY27 revenue, expense, operating-profit, earnings-per-share, or comparative prior-year profit figures. As a result, a year-on-year or sequential assessment of the September-quarter performance cannot be drawn from the stated results alone.
How were the September 2026 results approved and reviewed?
The Q2 FY27 results were considered by Deccan Health Care’s board at its meeting scheduled for Friday, November 13, 2026. The board agenda was to consider and approve un-audited standalone and consolidated results for the quarter and half year ended September 30, 2026.
The board-meeting disclosure was made under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation requires listed entities to give prior notice of board meetings at which financial results are considered.
The company said the financial statements were prepared under Indian Accounting Standard 34, or Ind AS 34, covering interim financial reporting. Keyur Shah & Associates, Chartered Accountants, conducted a limited review and issued reports on both the standalone and consolidated financial statements.
A limited review is distinct from a full-year audit. It is the review process generally applied to interim results and is intended to support the reported quarterly and half-yearly financial information. The article does not state any modification, qualification, or adverse observation in the auditor’s reports.
What are the key Q2 FY27 profit figures?
Deccan Health Care’s consolidated Q2 FY27 profit after tax was ₹39.84 lakh, which was ₹2.85 lakh higher than its standalone profit after tax of ₹36.99 lakh. For the first half, consolidated profit after tax exceeded the standalone figure by ₹7.33 lakh.
The half-year numbers include the outcome of the June 2026 quarter as well as the September 2026 quarter. Separately reported first-quarter FY27 information showed consolidated revenue of ₹22.09 crore, net income of ₹29.1 lakh, and earnings per share of ₹0.12. That context indicates that the half-year profit figure combines a ₹29.1 lakh first-quarter net income with the September-quarter result, though the figures are sourced from different reported summaries.
The company’s March 2026 consolidated net sales were reported at ₹20.98 crore, up 1.1% year on year. The disclosed March-quarter revenue and June-quarter revenue give some context on recent sales levels, but they cannot be used to calculate Q2 FY27 revenue because September-quarter sales were not included in the provided financial-results summary.
Got a follow-up? Ask IRIS
How does the result compare with Deccan Health Care’s recent financial context?
Recent reported data show Deccan Health Care operating in a relatively low-margin range despite revenue growth over the trailing period. For FY26, consolidated revenue was reported at ₹89 crore, up 18.69%, while net profit was ₹2 crore, up 91.2%.
Another trailing-twelve-month summary for FY26 placed revenue from operations at ₹75.06 crore, up 25.67%, and net profit at ₹1.16 crore, down 22.15%. The data sets use different reporting summaries and should not be treated as directly interchangeable. The key point for investors is that the September 2026 disclosure itself supplies profit figures but no complete revenue or margin bridge.
For Q1 FY27, revenue was reported as ₹22.09 crore, broadly unchanged from the first quarter of the previous year, while net income increased 23% to ₹29.1 lakh. The corresponding profit margin was stated at 1.3%, compared with 1.1% in Q1 FY26. This makes costs, working capital and the sustainability of profitability relevant areas when the company provides fuller financial details.
The company’s consolidated operating cash flow was ₹6.43 crore in FY26, compared with ₹12.55 crore in FY25. Cash generation is separate from accounting profit, but it remains an important measure for assessing how reported earnings translate into operating cash flows.
What does the Q2 FY27 update mean for investors and operations?
The Q2 FY27 update gives investors confirmed profit-after-tax figures for Deccan Health Care but does not provide enough information to assess revenue growth, operating margin movement, or the reasons behind the quarterly result. Investors therefore have a verified interim profitability disclosure rather than a complete operating-performance analysis.
The distinction between standalone and consolidated results is also relevant. Standalone numbers reflect the reporting entity’s own operations, while consolidated figures include the financial effect of entities covered under consolidation. In the September quarter, the consolidated profit after tax was modestly above the standalone result.
No share-price movement, management guidance, dividend decision, capacity update, or customer-related development was disclosed in the provided material. Similarly, no specific business segment, region or operational project was identified as a contributor to the Q2 outcome.
For the broader market, the filing is a scheduled earnings disclosure under listing regulations. Its immediate value is in updating the company’s reported half-year earnings record. Any conclusion on valuation, growth momentum or earnings quality would require the detailed financial statements, accompanying notes and future management communication.
Conclusion
Deccan Health Care reported consolidated profit after tax of ₹39.84 lakh for Q2 FY27 and ₹68.95 lakh for the first half ended September 30, 2026. Standalone profit after tax was ₹36.99 lakh for the quarter and ₹61.62 lakh for the half year, with the results prepared under Ind AS 34 and subject to limited review by Keyur Shah & Associates.
Investors should watch for the detailed September-quarter statements, including revenue, expenses, margins, cash-flow information and any management explanation of the result. The board meeting scheduled for November 13, 2026, was intended to consider and approve these un-audited standalone and consolidated results.


